Mitizodone Phosphate

磷酸嘧替佐酮

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameMitizodone Phosphate
Drug Alias NameHEC-30654AcOHHEC30654HEC-30654HEC-113995PA·H2OHEC113995PA•H2O
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsSerotonin 1a (5-HT1a) receptor partial agonists
TargetsSerotonin transporterSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepressionAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepression
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A